WESTFORD, Mass., Jan. 6, 2017 /PRNewswire/ -- Cynosure, Inc.
(Nasdaq: CYNO), which designs, manufactures and markets medical
devices for aesthetic procedures and precision surgical
applications worldwide, today announced that the Company will
release its fourth-quarter 2016 financial results before the market
opens on Tuesday, February 7, 2017
and host a conference call for investors and analysts that day at
9:00 a.m. ET.
On the call, President and Chief Executive Officer Michael Davin and Stephen Webber, the Company's Executive Vice
President and Chief Financial Officer, will discuss Cynosure's
financial results as well as the Company's business outlook and
strategy.
Those who wish to listen to the conference call webcast should
visit the "Investors" section of the Company's website at
www.cynosure.com. The live call also can be accessed by
dialing (877) 709-8155 or (201) 689-8881. If you are unable
to listen to the live call, the webcast will be archived on the
Company's website.
About Cynosure, Inc.
Cynosure develops, manufactures
and markets aesthetic treatment systems that enable plastic
surgeons, dermatologists and other medical practitioners to perform
non-invasive and minimally invasive procedures to remove hair,
treat vascular and benign pigmented lesions, remove multi-colored
tattoos, revitalize the skin, reduce fat through laser lipolysis,
reduce cellulite, clear nails infected by toe fungus, ablate sweat
glands and improve women's health. The Company also markets
radiofrequency (RF) energy-sourced medical devices for precision
surgical applications such as facial plastic and general surgery,
gynecology, ear, nose, and throat procedures, ophthalmology, oral
and maxillofacial surgery, podiatry and proctology. Cynosure's
product portfolio is composed of a broad range of energy sources
including Alexandrite, diode, Nd: YAG, picosecond, pulse dye,
Q-switched lasers, intense pulsed light and RF technology. Cynosure
sells its products globally under the Cynosure, Palomar, ConBio and
Ellman brand names through a direct sales force in the United States, Canada, France, Morocco, Germany, Spain, the United
Kingdom, Australia,
China, Japan and Korea, and through international
distributors in approximately 120 other countries. For corporate or
product information, visit Cynosure's website at
www.cynosure.com.
Contact
Scott
Solomon
Senior Vice President
Sharon Merrill Associates
617-542-5300
cyno@investorrelations.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cynosure-to-host-fourth-quarter-2016-financial-results-conference-call-on-february-7-300387134.html
SOURCE Cynosure, Inc.